Anemia Research Today is a free monthly online journal that collates and summarizes the latest research about Anemia, including details on symptoms, diagnosis, diet, treatment, causes.

Successful management of congenital dyserythropoietic anemia type I with interferon alpha in a child.

Yarali N, Fişgin T, Duru F, Atilla P, Müftüoğlu SF, Kaymaz SF

Dr. Sami Ulus Children's Hospital, Department of Pediatric Hematology, Ankara, Turkey. neseyarali@yahoo.com

Congenital dyserythropoietic anemia type I (CDA I) is a rare inherited hematological disorder characterized by macrocytic anemia and ineffective erythropoiesis with pathognomonic morphological features that include internuclear chromatin bridges, spongy heterochromatin, and invagination of the cytoplasm into the nuclear area in erythroid precursors. Treatment of anemia with the usual hematinics is without effect and 15% of patients need chronic transfusions. Successful treatment of CDA I with interferon-alpha was noted. The authors report a patient with CDA I who had required transfusions every 2-3 months since the neonatal period and responded to recombinant interferon-alpha therapy with the findings of electron microscopic investigations.

Published 15 July 2005 in Pediatr Hematol Oncol, 22(4): 265-70.
Full-text of this article is available online (may require subscription).

© 2004-2008 Anemia Research Today. All Rights Reserved.